Dr Batra’s® Healthcare Introduces World’s Most Advanced Treatment for Targeted Hereditary Hair Loss: XOGEN

New Delhi (India), June 27: Dr Batra’s® Healthcare, the world’s largest chain of homeopathic clinics, introduces a pioneering innovation with the launch of XOGEN, an exosome-based targeted hair treatment designed for men and women, to revolutionize the management of hereditary hair loss with its exosome-based formulation.

XOGEN represents a cutting-edge advancement in hair restoration, using a potent formula of 2 billion cells to regenerate hair. Clinically proven to show visible results in just three months. It stimulates stem cells for natural regrowth, nourishes follicles, reduces scalp inflammation and enhances blood flow for stronger, thicker hair. The process involves releasing growth factor-rich exosomes onto the scalp, which then migrate and latch onto damaged hair cells, deeply absorbing and delivering essential nutrients to promote repair and healing.

Commenting on the launch Dr. Akshay Batra, Vice-Chairman and Managing Director of Dr Batra’s® Healthcare and the first Indian President of the Trichological Society of London (UK) said, “We are thrilled to introduce XOGEN, the world’s most advanced exosome-based hair treatment. This targeted therapy and regeneration medicine accelerates hair growth and revitalizes hair follicles. XOGEN is the fastest treatment which gives best results even to those suffering from hereditary hair loss. At Dr Batra’s®, we are committed to providing the best possible treatments and ensuring our patients’ satisfaction.”